Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Taxes (2021 - 2025)

Corcept Therapeutics' Change in Taxes history spans 5 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Change in Taxes fell 15.6% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.1 million, down 71.09%, while the annual FY2025 figure was $1.1 million, 71.09% down from the prior year.
  • Change in Taxes for Q4 2025 was $1.0 million at Corcept Therapeutics, up from -$1.5 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $2.5 million in Q2 2022 and bottomed at -$1.5 million in Q3 2025.
  • The 5-year median for Change in Taxes is $579500.0 (2021), against an average of $738900.0.
  • The largest annual shift saw Change in Taxes soared 56950.0% in 2022 before it crashed 269.78% in 2025.
  • A 5-year view of Change in Taxes shows it stood at -$4000.0 in 2021, then skyrocketed by 56950.0% to $2.3 million in 2022, then crashed by 107.17% to -$163000.0 in 2023, then soared by 858.9% to $1.2 million in 2024, then dropped by 15.6% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Change in Taxes are $1.0 million (Q4 2025), -$1.5 million (Q3 2025), and $1.4 million (Q2 2025).